Tesla goes into its July 22 print with the strongest volume-and-margin setup in over a year — Q2 was its best-ever second quarter (~480K+ deliveries) and Q1 gross margin had already recovered 478bp YoY to 21.1% — yet the number that matters is operating margin, which fell to 4.2% in Q1 as AI/autonomy opex rose 37% YoY. The binding question the print resolves: is the core auto business now healthy enough to fund the robotaxi/Optimus build-out, or does the spend outrun a margin recovery that itself leans on a shrinking regulatory-credit crutch? That question is being asked into a week of autonomy setbacks — fresh federal robotaxi safety scrutiny, a rejected recall bid, and shareholders publicly pressing Musk on missed autonomy targets — which is exactly the narrative that carries the multiple.

Tesla goes into its July 22 print with the strongest volume-and-margin setup in over a year — Q2 was its best-ever second quarter (~480K+ deliveries) and Q1 gross margin had already recovered 478bp YoY to 21.1% — yet the number that matters is operating margin, which fell to 4.2% in Q1 as AI/autonomy opex rose 37% YoY. The binding question the print resolves: is the core auto business now healthy enough to fund the robotaxi/Optimus build-out, or does the spend outrun a margin recovery that itself leans on a shrinking regulatory-credit crutch? That question is being asked into a week of autonomy setbacks — fresh federal robotaxi safety scrutiny, a rejected recall bid, and shareholders publicly pressing Musk on missed autonomy targets — which is exactly the narrative that carries the multiple.

The bull-bear line for July 22 is not deliveries — those are already known (~480K+, best-ever Q2) — it is whether Tesla can grow into its AI spending without the automotive P&L cracking. Going in, we know the direction of both forces: gross margin has genuinely recovered (16.3% Q1'25 → 21.1% Q1'26, +478bp YoY), but operating margin has been compressed to 4.2% by opex up 37% YoY ($2,754M → $3,779M), led by R&D at $1,946M. Two structural swing factors to watch: regulatory-credit revenue is shrinking (Q1'26 $380M vs $595M a year earlier, and automotive GAAP margin drops from 21.1% to 19.2% ex-credits per the 8-K), and FSD subscriptions are inflecting up (1.28M, +51% YoY) into higher-margin Services & Other revenue (+42% YoY). The exogenous driver we explicitly do NOT forecast is the robotaxi/FSD autonomy commercialization and regulatory timeline, and the Optimus/AI valuation narrative — these are Musk-key-man, outside our substrate and unforecastable; our read is Tesla's LEVERAGE to them, not a call on approval dates. Note the setup: this is the same week federal regulators opened new robotaxi safety questions and NHTSA rejected a recall-avoidance bid, and shareholders are publicly pressing Musk on missed autonomy goals — so the print lands into a narrative already skeptical of the story that justifies the spend.